• 1
    Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006;49:837845.
  • 2
    Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007;62:3138.
  • 3
    Carnethon MR, Biggs ML, Barzilay JI et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the Cardiovascular Health Study. Arch Intern Med 2007;167:802807.
  • 4
    Mykletun A, Bjerkeset O, Dewey M, Prince M, ØVerland S, Stewart R. Anxiety, depression and cause-specific mortality: the HUNT Study. Psychosom Med 2007;69:323331.
  • 5
    Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, Mccants CB Jr, Sketch MH Jr. Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med 2006;68:651656.
  • 6
    Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005;111:480487.
  • 7
    Kubzansky LD, Davidson KW, Rozanski A. The clinical impact of negative psychological states: expanding the spectrum of risk for coronary artery disease. Psychosom Med 2005;67(Suppl. 1):S10S14.
  • 8
    Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004;66:316322.
  • 9
    Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897902.
  • 10
    Goldbacher EM, Matthews KA. Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Ann Behav Med 2007;34:240252.
  • 11
    Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007;62:12511257.
  • 12
    Heiskanen TH, Niskanen LK, Hintikka JJ et al. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006;67:14221427.
  • 13
    Roriz-cruz M, Rosset I, Wada T et al. Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 2007;55:374382.
  • 14
    Gil K, Radzillowicz P, Zdrojewski T et al. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project. Kardiol Pol 2006;64:464469.
  • 15
    Räikkönen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002;51:15731577.
  • 16
    Herva A, Räsänen P, Miettunen J et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006;68:213216.
  • 17
    Vogelzangs N, Suthers K, Ferrucci L et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007;32:151159.
  • 18
    Vogelzangs N, Beekman AT, Kritchevsky SB et al. Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci 2007;62:563569.
  • 19
    Räikkönen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 2007;30:872877.
  • 20
    Holmen J, Midthjell K, Krüger Ø et al. The Nord-Trøndelag Health Study 1995–97 (HUNT 2): objectives, contents, methods and participation. N J Epidemiol 2003;13:1932.
  • 21
    Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007;7:220.
  • 22
    Bjelland I, Dahl AA, Tangen haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:6977.
  • 23
    Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469480.
  • 24
    Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National heart, lung, and blood institute scientific statement. Circulation 2005;112:27352752.
  • 25
    Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:24862497.
  • 26
    Simon GE, Von korff M, Saunders K et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006;63:824830.
  • 27
    Weber-hamann B, Werner M, Hentschel F et al. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006;31:347354.
  • 28
    Rivenes AC, Harvey SB, Mykletun A. The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT Study. J Psychosom Res (in press).
  • 29
    Hildrum B, Mykletun A, Stordal E, Bjelland I, Dahl AA, Holmen J. Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study. J Epidemiol Community Health 2007;61:5358.
  • 30
    Hildrum B, Mykletun A, Holmen J, Dahl AA. Effect of anxiety and depression on blood pressure: 11-year longitudinal population study. Br J Psychiatry 2008;193:108113.
  • 31
    Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA. Depression and diabetes. A large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 2005;28:19041909.
  • 32
    Carney RM, Freedland KE, VEITH RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005;67(Suppl. 1):S29S33.
  • 33
    Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998;21:293307.
  • 34
    Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metab 2006;91:718721.
  • 35
    Stordal E, Mykletun A, Dahl AA. The association between age and depression in the general population: a multivariate examination. Acta Psychiatr Scand 2003;107:132141.
  • 36
    Mykletun A, Overland S, Dahl AA et al. A population-based cohort study of the effect of common mental disorders on disability pension awards. Am J Psychiatry 2006;163:14121418.
  • 37
    Birkenaes AB, Birkeland KI, Engh JA et al. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 2008;28:132137.
  • 38
    Anonymous. Drug Consumption in Norway 1994–1998. Oslo: Norsk Medisinaldepot, 1999, ISBN 82-90312-29-6.
  • 39
    Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001;158:10911098.